Egle Therapeutics inks $46.4m Series A
Egle Therapeutics SAS, an emerging biotechnology company, has raised $46.4 million in Series A financing.
Egle Therapeutics SAS, an emerging biotechnology company, has raised $46.4 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination